Aziyo Logo.jpg
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock
December 01, 2022 09:04 ET | Aziyo Biologics
SILVER SPRING, Md., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Logo.jpg
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
November 30, 2022 16:08 ET | Aziyo Biologics
SILVER SPRING, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility...
Aziyo Logo.jpg
Aziyo Biologics to Participate in Upcoming Investor Conferences
November 21, 2022 16:05 ET | Aziyo Biologics
SILVER SPRING, Md., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility between...
Aziyo Logo.jpg
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
November 14, 2022 16:01 ET | Aziyo Biologics
Positive meeting with FDA provides clarity for CanGaroo® RM clearance SILVER SPRING, Md., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a...
Aziyo Logo.jpg
Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022 16:05 ET | Aziyo Biologics
SILVER SPRING, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced that it will...
Aziyo Logo.jpg
Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors
October 24, 2022 08:00 ET | Aziyo Biologics
SILVER SPRING, Md., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a regenerative medicine company with a portfolio of commercial therapies, today announced the appointment...
Aziyo Logo.jpg
Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets
October 11, 2022 16:35 ET | Aziyo Biologics
SILVER SPRING, Md., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biological device company with a portfolio of commercial products across four distinct businesses, today...
Aziyo Logo.jpg
Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer
August 26, 2022 09:00 ET | Aziyo Biologics
SILVER SPRING, Md., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company announced today that Michelle LeRoux Williams, Ph.D. has...
Aziyo Logo.jpg
Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 17, 2022 16:05 ET | Aziyo Biologics
SILVER SPRING, Md., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced the company will present at the upcoming...
Aziyo Logo.jpg
Aziyo Biologics Announces Second Quarter 2022 Financial Results and Recent Business Achievements, Including Robust Revenue Growth and Strengthened Balance Sheet
August 11, 2022 16:05 ET | Aziyo Biologics
SILVER SPRING, Md., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today provided a business update and reported financial...